Bowel symptoms in patients with primary Sjögren's syndrome [5]

Scandinavian Journal of Rheumatology

Volumn 36, Issue 5, 2007, Pages 407-409

  Krogh, K ^a   Asmussen, K ^b   Stengaard Pedersen, K ^a   Laurberg, S ^a   Deleuran, B W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LAXATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PILOCARPINE;

CLINICAL PRACTICE; CONNECTIVE TISSUE DISEASE; ENTEROPATHY; EXOCRINE GLAND; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT FUNCTION; HUMAN; LETTER; LYMPHOCYTIC INFILTRATION; POLYMYOSITIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

CONSTIPATION; DEFECATION; GASTROINTESTINAL DISEASES; HUMANS; INTESTINAL MUCOSA; PAIN; SJOGREN'S SYNDROME;

EID: 35648953359     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701340222     Document Type: Letter

References (10)

1. Vitali C, Bombardieri S, Jonsson R, Moutsopolous HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
2. Trezza M, Krogh K, Egekvist H, Bjerring P, Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999;34:409-13.
3. Wegener M, Adamek RJ, Wedman B, Jergas M, Altmeyer P. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994;39:2209-15.
4. Battle WM, Snape WJ, Wright S, Sullivan MA, Cohen S, Meyers A, et al. Abnormal colonic motility in progressive systemic sclerosis. Ann Intern Med 1981;94:749-52.
5. Whitehead WE, Taitelbaum G, Wigley FM, Schuster MM. Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis. Gastroenterology 1989;6:428-32.
6. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998;93:1085-9.
7. Agachan F, Chen T, Pfeifer J, Reismann P, Wexner S. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 1996;39:581-5.
8. Howe S Eaker EY, Sallustio JE, Peebles C, Tan EM, Williams RC. Antimyenteric neuronal antibodies in scleroderma. J Clin Invest 1994;94:761-70.
9. Goldblatt F, Gordon TP, Waterman SA. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002;123:1144-50.
10. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000;43:1647-54.